Stay informed with the latest updates for the inheritable blood disorders community. Industry Takeda Announces Trial Results on Investigational Therapy for…Jan 10, 2023 Industry Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…Jan 4, 2023 Industry Spark Announces SPK-8011 Updates at ASHDec 15, 2022 Industry BioMarin Shares Community Update for Valoctocogene RoxaparvovecOct 3, 2022 Industry Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial Sep 23, 2022 Industry FDA Grants Priority Review for Sanofi’s BIVV001Sep 6, 2022 Industry Rare Factor X Deficiency Survey Shows Disparity in Care Sep 1, 2022 Industry BioMarin Receives Conditional Approval in Europe for Gene TherapyAug 25, 2022 Industry BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTHAug 4, 2022 Industry New Prophylaxis Approval for REBINYN®Aug 3, 2022 Industry Sanofi Provides Fitusiran Trial Updates at ISTHJul 25, 2022 Industry Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…Jul 22, 2022 Industry Sanofi and Sobi® Report Progress with BIVV001 at International Congress Jul 20, 2022 Industry Bayer Announces Discontinuation of Kogenate® FSJun 2, 2022 Industry FDA Grants Breakthrough Status to BIVV001 Jun 1, 2022 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page